Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives

Volume: 11, Issue: 4, Pages: 329 - 340
Published: Aug 1, 2021
Abstract
The continuous neuroinflammatory and neurodegenerative pathology in multiple sclerosis (MS) results in irreversible accumulation of physical and cognitive disability. Reliable early detection of MS disease processes can aid in the diagnosis, monitoring and treatment management of MS patients. Recent assay technological advancements now allow reliable quantification of serum-based neurofilament light chain (sNfL) levels, which provide temporal...
Paper Details
Title
Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives
Published Date
Aug 1, 2021
Volume
11
Issue
4
Pages
329 - 340
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.